Nurix Therapeutics, Inc.NRIXNASDAQ
LOADING
|||
Revenue Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
71.99%
↑ 335% above average
Average (27q)
16.54%
Historical baseline
Range
High:141.83%
Low:-82.40%
Volatility
1355.7%
High variability
| Period | Value |
|---|---|
| Q4 2025 | 71.99% |
| Q3 2025 | -82.08% |
| Q2 2025 | 138.75% |
| Q1 2025 | 38.91% |
| Q4 2024 | 5.53% |
| Q3 2024 | 4.10% |
| Q2 2024 | -27.09% |
| Q1 2024 | 9.41% |
| Q4 2023 | -17.91% |
| Q3 2023 | -39.80% |
| Q2 2023 | 141.83% |
| Q1 2023 | 87.01% |
| Q4 2022 | -37.14% |
| Q3 2022 | -5.61% |
| Q2 2022 | 18.82% |
| Q1 2022 | 30.08% |
| Q4 2021 | -27.86% |
| Q3 2021 | 44.58% |
| Q2 2021 | 41.51% |
| Q1 2021 | -25.09% |
| Q4 2020 | 63.75% |
| Q3 2020 | -2.32% |
| Q2 2020 | 46.02% |
| Q1 2020 | 53.81% |
| Q4 2019 | -82.40% |
| Q3 2019 | 12.09% |
| Q2 2019 | 2.22% |
| Q1 2019 | 0.00% |